Outset Medical (OM) Set to Announce Earnings on Wednesday

Outset Medical (NASDAQ:OM) is scheduled to be posting its quarterly earnings results after the market closes on Wednesday, November 6th. Analysts expect Outset Medical to post earnings of ($0.42) per share for the quarter. Outset Medical has set its FY 2024 guidance at EPS.Individual interested in registering for the company’s earnings conference call can do so using this link.

Outset Medical (NASDAQ:OM) last posted its quarterly earnings data on Wednesday, August 7th. The company reported ($0.66) EPS for the quarter, missing the consensus estimate of ($0.59) by ($0.07). Outset Medical had a negative net margin of 136.72% and a negative return on equity of 143.52%. The firm had revenue of $27.39 million during the quarter, compared to analysts’ expectations of $31.19 million. During the same quarter in the previous year, the company posted ($0.90) EPS. On average, analysts expect Outset Medical to post $-3 EPS for the current fiscal year and $-2 EPS for the next fiscal year.

Outset Medical Trading Up 1.7 %

Outset Medical stock opened at $0.62 on Tuesday. Outset Medical has a 12 month low of $0.44 and a 12 month high of $6.37. The company has a current ratio of 6.80, a quick ratio of 5.38 and a debt-to-equity ratio of 2.87. The business’s 50 day simple moving average is $0.57 and its 200 day simple moving average is $2.32.

Analyst Ratings Changes

Several research firms recently commented on OM. TD Cowen dropped their price objective on Outset Medical from $9.00 to $3.00 and set a “buy” rating on the stock in a research note on Thursday, August 8th. Royal Bank of Canada downgraded Outset Medical from an “outperform” rating to a “sector perform” rating and dropped their price objective for the company from $6.00 to $3.00 in a research note on Thursday, August 8th. Two investment analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $4.70.

Outset Medical Company Profile

Outset Medical, Inc, a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.